Institutional Ownership Xenon Pharmaceuticals Inc. (XENE)
This table provides information about the institutional ownership of Xenon Pharmaceuticals Inc. (XENE). We have compiled data on the 212 institutions that hold shares in the stock, with a total of 70.5 Million shares, which have been reported (via 13F filing form) to have a value of $2.85 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
243,579
shares
|
$9.74 Million
0.02% of portfolio
|
Q3 2024
Added 24.83%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
239,942
shares
|
$9.59 Million
0.0% of portfolio
|
Q3 2024
Added 0.49%
|
|
|
Assenagon Asset Management S.A.
|
Jan 14, 2025 Q4 2024 |
238,522
shares
|
$9.54 Million
0.02% of portfolio
|
Q4 2024
Added 12.36%
|
|
|
Russell Investments Group, Ltd.
|
Nov 13, 2024 Q3 2024 |
223,614
shares
|
$8.94 Million
0.01% of portfolio
|
Q3 2024
Added 37.31%
|
|
|
Algert Global LLC
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
219,645
shares
|
$8.78 Million
0.23% of portfolio
|
Q3 2024
Added 19.89%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 12, 2024 Q3 2024 |
215,822
shares
|
$8.63 Million
0.0% of portfolio
|
Q3 2024
Reduced 75.1%
|
|
|
Putnam Investments LLC
Boston, MA |
Feb 14, 2024 Q4 2023 |
215,545
shares
|
$8.62 Million
0.01% of portfolio
|
Q4 2023
Added 25.36%
|
|
|
Ally Bridge Group (Ny) LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
211,791
shares
|
$8.47 Million
5.92% of portfolio
|
Q3 2024
Added 25.05%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
209,026
shares
|
$8.36 Million
0.0% of portfolio
|
Q3 2024
Added 19.05%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
204,892
shares
|
$8.19 Million
0.01% of portfolio
|
Q3 2024
Added 26.69%
|
|
|
Granahan Investment Management, LLC
Waltham, MA |
Nov 14, 2024 Q3 2024 |
200,877
shares
|
$8.03 Million
0.33% of portfolio
|
Q3 2024
Reduced 11.18%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Nov 14, 2024 Q3 2024 |
191,658
shares
|
$7.66 Million
1.06% of portfolio
|
Q3 2024
Reduced 8.42%
|
|
|
Axa S.A.
Paris, I0 |
Nov 14, 2024 Q3 2024 |
188,090
shares
|
$7.52 Million
0.02% of portfolio
|
Q3 2024
Added 0.03%
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
179,878
shares
|
$7.19 Million
0.42% of portfolio
|
Q3 2024
Added 19.48%
|
|
|
Schroder Investment Management Group
London, X0 |
Nov 13, 2024 Q3 2024 |
176,674
shares
|
$7.06 Million
0.01% of portfolio
|
Q3 2024
Added 93.09%
|
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
Dec 13, 2024 Q3 2024 |
173,985
shares
|
$6.96 Million
0.02% of portfolio
|
Q3 2024
Reduced 8.44%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Nov 12, 2024 Q3 2024 |
165,800
shares
|
$6.63 Million
1.02% of portfolio
|
Q3 2024
New holding
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Nov 14, 2024 Q3 2024 |
163,064
shares
|
$6.52 Million
0.01% of portfolio
|
Q1 2024
Reduced 0.8%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
162,683
shares
|
$6.5 Million
0.0% of portfolio
|
Q3 2024
Added 0.13%
|
|
|
Bridger Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
146,800
shares
|
$5.87 Million
2.95% of portfolio
|
Q1 2024
New holding
|
|
|
New York State Common Retirement Fund
|
Jan 31, 2025 Q4 2024 |
132,521
shares
|
$5.3 Million
0.01% of portfolio
|
Q3 2024
Reduced 12.14%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
127,456
shares
|
$5.1 Million
0.0% of portfolio
|
Q3 2024
Reduced 10.45%
|
|
|
Atika Capital Management LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
126,000
shares
|
$5.04 Million
0.57% of portfolio
|
Q3 2024
Added 1.61%
|
|
|
Swiss National Bank
Zurich, V8 |
Nov 07, 2024 Q3 2024 |
125,300
shares
|
$5.01 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.63%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Nov 14, 2024 Q3 2024 |
107,187
shares
|
$4.29 Million
0.74% of portfolio
|
Q1 2024
New holding
|